Identification of a potent new chemotype for the selective inhibition of PDE4

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

A series of substituted 3,6-diphenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines were prepared and analyzed as inhibitors of phosphodiesterase 4 (PDE4). Synthesis, structure-activity relationships, and the selectivity of a highly potent analogue against related phosphodiesterase isoforms are presented.

Knowledge Graph

Similar Paper

Identification of a potent new chemotype for the selective inhibition of PDE4
Bioorganic & Medicinal Chemistry Letters 2008.0
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of triazines as potent, selective and orally active PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Design and synthesis of 4,5,6,7‐tetrahydro‐1 H ‐1,2‐diazepin‐7‐one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors
Bioorganic & Medicinal Chemistry Letters 2017.0
8-Substituted Analogues of 3-(3-Cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl- adenine: Highly Potent and Selective PDE4 Inhibitors
Journal of Medicinal Chemistry 2005.0
Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure−Activity Relationships of 4-Aryl-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
Journal of Medicinal Chemistry 2001.0
Synthesis and structure–activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1- hi ]indoles: novel PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2000.0
Rhodanine derivatives as novel inhibitors of PDE4
Bioorganic & Medicinal Chemistry Letters 2008.0
Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
Bioorganic & Medicinal Chemistry Letters 2001.0